1. Home
  2. RDW vs WVE Comparison

RDW vs WVE Comparison

Compare RDW & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwire Corporation

RDW

Redwire Corporation

HOLD

Current Price

$8.22

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$17.15

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDW
WVE
Founded
2020
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
RDW
WVE
Price
$8.22
$17.15
Analyst Decision
Buy
Strong Buy
Analyst Count
7
16
Target Price
$12.67
$29.94
AVG Volume (30 Days)
10.8M
13.7M
Earning Date
11-05-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$296,147,000.00
$109,230,000.00
Revenue This Year
$11.62
N/A
Revenue Next Year
$42.89
$31.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
103.75
52 Week Low
$4.87
$5.28
52 Week High
$26.66
$21.73

Technical Indicators

Market Signals
Indicator
RDW
WVE
Relative Strength Index (RSI) 63.65 64.83
Support Level $6.32 $15.23
Resistance Level $8.20 $17.41
Average True Range (ATR) 0.79 2.02
MACD 0.24 0.14
Stochastic Oscillator 77.47 68.65

Price Performance

Historical Comparison
RDW
WVE

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: